Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’

類似資料

• Reply: Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
  著者:: Feliu, J, 等
  出版事項: (2011)
• Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
  著者:: Feliu, J, 等
  出版事項: (2010)
• Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer
  著者:: García-Alfonso, P, 等
  出版事項: (2010)
• Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
  著者:: Dyar, Stephen, 等
  出版事項: (2011)
• Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
  著者:: Stephen Dyar, 等
  出版事項: (2011-01-01)